News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rational Therapeutics Release: Targeted Cancer Therapy Improved with Ex-Vivo Chemosensitivity Analysis


6/1/2007 1:36:40 PM

LONG BEACH, Calif. & CHICAGO--(BUSINESS WIRE)--Researchers at Rational Therapeutics (Long Beach, Calif.) www.rationaltherapeutics.com have reported clinical results obtained with a laboratory technique (Ex-Vivo Analysis of Programmed Cell Death – EVA-PCD™) that accurately identifies patients who are candidates for targeted cancer therapy.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES